Explore the words cloud of the XSpectra project. It provides you a very rough idea of what is the project "XSpectra" about.
The following table provides information about the project.
|Coordinator Country||Italy [IT]|
|Total cost||3˙252˙461 €|
|EC max contribution||2˙276˙722 € (70%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2019-04-01 to 2021-03-31|
Take a look of project's partnership.
Xnext is a small Italian high-tech company that has the ambition of revolutionizing the quality inspection in the food sector and the ultimate goal of providing a decisive contribution for the solution of food contamination problems. We aim at succeeding thanks to XSpectra®, the most advanced real time inspection detector. XSpectra® is a disruptive technology as it overcomes all the weaknesses of conventional technologies, thus determining a relevant technological leap compared to all the existing solutions. Based on X-ray multi-spectrum analysis, XSpectra® is capable, like no other technology, to analyze real time the physical-chemical features of the materials and identify foreign bodies currently not detectable. The result of over 8 years of R&D, it’s a very complex system, combining 3 high innovations, all industrialized in-house: Photonics, Nuclear Electronics and Deep Learning Artificial Intelligence Algorithms. XSpectra® is beneficial for the food producers as it improves significantly the production efficiency (minimizing the product batch discard as well as the costs for product recalls); for the consumer as it guarantees the highest safety standards for the quality of foodstuff; for the environment as it helps to reduce significantly the amount of wasted food from the production line. XSpectra® has successfully completed the industrial prototype testing and is now installed for a field test on a production line. At the end of the project we will release the final industrial product and begin the commercialization worldwide. Thanks to high versatility of the system and the chemical-physical characterization capability, XSpectra® can be applied in several other fields: Pharma, Non-Destructive-Tests, material recycling, security controls, just to mention a few. Xnext intends to exploit the cash generation coming from the application in the food sector to support the application of XSpectra® in other sectors that also need to improve the quality standar
|year||authors and title||journal||last update|
Manuele Bettelli, Nicola Sarzi AmadÃ¨, Davide Calestani, Bruno Garavelli, Pietro Pozzi, Daniele Macera, Luca Zanotti, Carlo Andrea Gonano, Matthew C. Veale, Andrea Zappettini
A first principle method to simulate the spectral response of CdZnTe-based X- and gamma-ray detectors
published pages: 163663, ISSN: 0168-9002, DOI: 10.1016/j.nima.2020.163663
|Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 960||2020-04-17|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "XSPECTRA" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "XSPECTRA" are provided by the European Opendata Portal: CORDIS opendata.
Interactive Digital Signage with emotional intelligence for smart citiesRead More
Reliable, real-time process monitoring solutions for gold mines to reduce costs, reagent use and increase gold productionRead More
Wearable technology for the selective detection and continuous monitoring of movement disorders related to Parkinson’s diseaseRead More